OptixDX Enables Early Detection of Wound Complications to Drive Proactive Clinical Intervention
The OptixDX imaging platform was developed to support early detection and monitoring of wound complications, with a focus on integrating the technology into routine clinical care for both acute and chronic wound patients. Patient engagement informed key design decisions related to usability, imaging workflows, and how the technology fits into patients’ care experiences and daily lives.
Quick Facts Organization name: Pretika MedTech |
Product Type(s)
medical device:
- home-use device
diagnostic product:
- imaging
digital health technology:
- digital diagnostic
Product Medical Specialty Area(s)
- general and plastic surgery
- general hospital
- orthopedic
- physical medicine
- radiology
- other: chronic disease
Stakeholders
- medtech company: internal discovery/research and development (R&D) teams
- medtech company: internal clinical affairs/R&D teams
- other: intellectual property staff
Methods and Sources of Patient Input
- real-world data/evidence
- other: retrospective and prospective studies
- other: national and regional hospital sites
Purpose of Patient Engagement
Patient engagement activities within the hospital study were pursued to ensure that OptixDX’s imaging and diagnostic workflow development aligned with real-world patient needs, experiences, and care pathway challenges associated with acute and chronic wounds. The primary goal was to capture patient perspectives on the burden of wound monitoring, visit frequency, comfort with imaging modalities, dressing integration, and tolerance for repeat assessments. Insights were also sought regarding anxiety related to complications, infection risk, healing uncertainty, and the desire for earlier visibility into wound status.
These activities informed the design of a noninvasive imaging approach embedded within standard wound care without disrupting healing or daily living. Additional objectives included understanding patient preferences for data sharing, remote monitoring acceptability, and communication of imaging results to support engagement in their care plans.
Ultimately, the information gathered was intended to guide product usability, clinical workflow integration, and study protocol design, ensuring that early complication detection, longitudinal monitoring, and proactive intervention capabilities were developed in a manner that is patient-centered, clinically actionable, and scalable across surgical and chronic wound populations.
Description of Patient Engagement Activities
The need for patient engagement was illuminated through early clinical collaboration and workflow observations within Hoag’s wound care and surgical programs, where variability in healing trajectories, delayed complication detection, and patient burden associated with frequent in-person assessments were identified. Clinicians highlighted the importance of incorporating the patient voice to ensure imaging solutions would be tolerable, nondisruptive to dressings, and supportive of home and outpatient care settings.
Patients and caregivers were identified through Hoag’s existing acute and chronic wound populations, including postsurgical, diabetic foot ulcer, and pressure injury cohorts. Engagement occurred via structured interviews, observational use-case assessments, and patient experience surveys conducted in conjunction with imaging evaluations. Data and input collected included comfort with imaging procedures, dressing integration considerations, visit cadence preferences, perceptions of infection risk, willingness to participate in remote monitoring, and desired clarity/timing of wound status communication. Feedback was gathered at initial imaging encounters and longitudinally at follow-up visits to assess changes over the healing continuum. Input was used to refine device form factor, imaging frequency, workflow placement, and reporting outputs, ensuring the solution supports early complication detection; minimizes patient burden; and enables proactive, patient-centered clinical intervention.
Impact of Patient Engagement
Patient engagement in the Hoag study provided tangible and perceived benefits across the company, patients/caregivers, and clinical partners.
For the company, patient insights informed device design, imaging workflow, and dressing integration, reducing usability risks and supporting adoption readiness. Feedback on comfort, monitoring preferences, and visit cadence optimized longitudinal imaging frequency and reinforced a noninvasive, patient-centered approach. This guidance de-risked clinical study design and strengthened the value proposition for regulators, providers, and investors.
Patients and caregivers gained a sense of inclusion and empowerment, contributing to the shaping of technology that directly affects their care. Engagement increased confidence in proactive monitoring, reassurance from early detection of complications, and comfort with home or outpatient use.
For providers and research partners, patient input improved protocol feasibility, visit planning, and compliance, aligning device deployment with real-world clinical workflows.
Collectively, these activities enhanced study execution, informed scalable implementation, and reinforced the shared objective of proactive, outcomes-focused wound care.
Lessons Learned
The patient engagement effort highlighted the critical value of incorporating patient perspectives early in the R&D process. Insights revealed gaps between clinical assumptions and real-world patient experiences, particularly related to usability, comfort, and workflow integration. Patients emphasized clarity in instructions, minimal disruption to daily routines, and the importance of timely feedback on health outcomes.
These findings will guide future R&D by prioritizing human-centered design, enhancing device accessibility, and aligning feature development with patient needs. Additionally, direct patient input informed risk-benefit considerations and shaped communication strategies for clinical studies. Overall, this engagement reinforced that continuous patient collaboration is essential for creating solutions that are both clinically effective and meaningful to end users.